Literature DB >> 34668541

Mid- to late-gestational maternal nutrient restriction followed by realimentation alters development and lipid composition of liver and skeletal muscles in ovine fetuses.

Brandon I Smith1, Amanda Liefeld1, Manuel A Vásquez-Hidalgo2, Kimberly A Vonnahme2, Anna T Grazul-Bilska2, Kendall C Swanson2, Neha Mishra3, Sarah A Reed1, Steven A Zinn1, Kristen E Govoni1.   

Abstract

Maternal nutrient restriction during gestation adversely affects offspring growth and development of liver and skeletal muscle tissues. Realimentation following nutrient restriction may alleviate these negative impacts on development but may alter metabolism and tissue composition. Forty-eight ewes, pregnant with singletons, were fed to meet 100% National Research Council (NRC) recommendations starting at the beginning of gestation. On day 50 of gestation, seven ewes were euthanized (BASE), and fetal liver, skeletal muscles, and blood samples were collected. The remaining animals were fed either 100% of NRC recommendations (CON) or 60% NRC recommendations (RES), a subset were euthanized at day 90 of gestation (n = 7/treatment), and fetal samples were collected. Remaining ewes were maintained on the current diet (CON-CON, n = 6; RES-RES, n = 7) or switched to the alternate diet (CON-RES, RES-CON; n = 7/treatment). On day 130 of gestation, the remaining ewes were euthanized, and fetal samples were collected. At day 130 of gestation, maternal nutrient restriction during late-gestation (RES-RES and CON-RES) decreased fetal liver weight (P < 0.01) and cross-sectional area in triceps brachii (P = 0.01; TB), longissimus dorsi (P = 0.02; LM), and semitendinosus (P = 0.05; STN) muscles. Maternal nutrient restriction during mid-gestation increased hepatocyte vacuole size at day 130 of gestation. Late-gestational maternal nutrient restriction increased mRNA expression of insulin-like growth factor (IGF) binding protein-1 (P < 0.01), glycogen synthase 2 (P = 0.01; GYS2), and pyruvate dehydrogenase kinase 1 (P < 0.01; PDHK1) in the liver and IGF receptor 1 (P = 0.05) in the LM. Lipid concentration in the LM was decreased by late-gestational nutrient restriction (P = 0.01) and increased by mid-gestational nutrient restriction in STN (P = 0.03) and TB (P < 0.01). Principal component analysis of lipidomics data demonstrated clustering of principal components by day of gestation and elastic net regression identified 50, 44, and 29 lipids that classified the treatments in the fetal liver, LM, and blood, respectively. In conclusion, restricting maternal nutrition impacts fetal liver and muscle morphology, gene expression, and lipid metabolism, whereas realimentation attenuated some of these effects. Therefore, realimentation may be a viable strategy to reduce the impacts of nutrient restriction, but can lead to alterations in lipid metabolism in sheep.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  fetal programming; liver; maternal nutrition; realimentation; ruminant; skeletal muscle

Mesh:

Substances:

Year:  2021        PMID: 34668541      PMCID: PMC8659357          DOI: 10.1093/jas/skab299

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.338


  60 in total

Review 1.  Mechanisms of reduced and compensatory growth.

Authors:  J L Hornick; C Van Eenaeme; O Gérard; I Dufrasne; L Istasse
Journal:  Domest Anim Endocrinol       Date:  2000-08       Impact factor: 2.290

Review 2.  Fetal programming in meat production.

Authors:  Min Du; Bo Wang; Xing Fu; Qiyuan Yang; Mei-Jun Zhu
Journal:  Meat Sci       Date:  2015-04-23       Impact factor: 5.209

3.  Early developmental influences on hepatic organogenesis.

Authors:  Melanie A Hyatt; Helen Budge; Michael E Symonds
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

4.  Effects of maternal undernutrition during late pregnancy on the development and function of ovine fetal liver.

Authors:  Feng Gao; Yingchun Liu; Lingyao Li; Ming Li; Chongzhi Zhang; Changjin Ao; Xianzhi Hou
Journal:  Anim Reprod Sci       Date:  2014-05-05       Impact factor: 2.145

Review 5.  Skeletal muscle metabolism during exercise in humans.

Authors:  M Hargreaves
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-03       Impact factor: 2.557

6.  Intravenous Triacylglycerol Infusion Promotes Ceramide Accumulation and Hepatic Steatosis in Dairy Cows.

Authors:  J Eduardo Rico; Sarah L Giesy; Norman J Haughey; Yves R Boisclair; Joseph W McFadden
Journal:  J Nutr       Date:  2018-10-01       Impact factor: 4.798

Review 7.  Insulin resistance and elevated triglyceride in muscle: more important for survival than "thrifty" genes?

Authors:  S R Stannard; N A Johnson
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182

8.  Glycogen metabolism in late gestation in fetuses of maternal diabetic rats.

Authors:  R N Margolis; D Seminara
Journal:  Biol Neonate       Date:  1988

Review 9.  Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise.

Authors:  Michael P Corcoran; Stefania Lamon-Fava; Roger A Fielding
Journal:  Am J Clin Nutr       Date:  2007-03       Impact factor: 7.045

Review 10.  Functions and the Emerging Role of the Foetal Liver into Regenerative Medicine.

Authors:  Antonella Giancotti; Marco Monti; Lorenzo Nevi; Samira Safarikia; Valentina D’Ambrosio; Roberto Brunelli; Cristina Pajno; Sara Corno; Violante Di Donato; Angela Musella; Michele Francesco Chiappetta; Daniela Bosco; Pierluigi Benedetti Panici; Domenico Alvaro; Vincenzo Cardinale
Journal:  Cells       Date:  2019-08-16       Impact factor: 6.600

View more
  1 in total

1.  Poor maternal diet during gestation alters offspring muscle proteome in sheep.

Authors:  Sarah A Reed; Jeremy Balsbaugh; Xiaomeng Li; Timothy E Moore; Amanda K Jones; Sambhu M Pillai; Maria L Hoffman; Kristen E Govoni; Steven A Zinn
Journal:  J Anim Sci       Date:  2022-08-01       Impact factor: 3.338

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.